ITRIItron, Inc.

$85.61-29% 1Y

Is the business good?

Good

A genuinely good business: earnings fully cash-backed (1.6×) and margins widening.

2 good, 2 neutral
Fundamental health (F-score)6 / 9SEC EDGAR · Dec 31, 2025

Mixed fundamental signals. Nine pass/fail tests of year-over-year health from the filings.

Profits arrive as cash1.58×derived · Jun 30, 2026

Operating profit is fully backed by cash. Conversion is improving vs a year ago.

Margin direction, 3 years+11.0 pts

Operating margin has widened over the past few years, the business is getting more profitable per dollar of sales.

Where ROE comes from7% ROA

A balanced mix of margins, efficiency, and leverage. ROE 17% = margin × turnover × leverage.

Unless marked, from derived.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

FCF conversionbetter than 70% of the market
Leverage (Debt/EBITDA)behind 70% of the market

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is ITRI?

Itron, Inc. earns 9.8% on the capital it employs against a 9.0% cost of capital, so the business is worth more the bigger it gets.

9.8%

Return on invested capital · cost of capital 9.0% · 0.82 points above what the capital costs: growth creates value

Operating margin
13%

Operating margin · Scientific & Technical Instruments median 16% · 12 months to Q2 2026

Cash conversion
1.58×

Cash conversion · 1.27× a year ago · operating cash flow covers the operating profit after tax

Share count, year on year
−3.8%

Share count, year on year · bought back, each share owns more of the company

Operating margin by fiscal year
YearOperating margin
FY2020−0.48%
FY2021−4.0%
FY2022−0.41%
FY20235.9%
FY202411%
FY202513%
Details›
Gross margin12 months to Q2 2026
40%
Operating margin12 months to Q2 2026
13%
Net margin12 months to Q2 2026
12%
Free cash flow margin
17%
R&D as % of revenue
9.3%
Revenue, trailing twelve months
$2.30B
Free cash flow, trailing twelve months
$385M
Net income, trailing twelve months
$274M
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
9.8%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.